Welcome to our dedicated page for Viemed Healthcare SEC filings (Ticker: VMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for Viemed Healthcare’s shifting Medicare reimbursement disclosures or payor-mix trends before the next earnings call? Start here. Our SEC filings hub gathers every VMD document the moment it hits EDGAR, so you can move straight to the schedules that explain how home-ventilation revenue, equipment rentals, and neuromuscular therapy services impact cash flow and compliance.
Use Stock Titan’s AI to translate dense language into clear takeaways: Viemed Healthcare quarterly earnings report 10-Q filing summaries spotlight segment margins; Viemed Healthcare annual report 10-K simplified highlights list CMS rule changes and readmission-rate data; and Viemed Healthcare 8-K material events explained alerts you to sudden reimbursement updates or payer audits. Real-time monitors push Viemed Healthcare Form 4 insider transactions real-time so you can see executive stock moves alongside Viemed Healthcare executive stock transactions Form 4 commentary. Need governance data? The Viemed Healthcare proxy statement executive compensation section parses bonus triggers tied to patient-outcome metrics.
Whether you’re screening for policy risk, modeling DME inventory turns, or tracking Viemed Healthcare insider trading Form 4 transactions, our platform answers the questions professionals actually ask: “understanding Viemed Healthcare SEC documents with AI,” “Viemed Healthcare earnings report filing analysis,” and “Viemed Healthcare SEC filings explained simply.” Skip the 300-page PDFs—AI-powered summaries, keyword search, and downloadable tables let you compare trends, flag anomalies, and act with confidence.
Michael Moore, President of Viemed Healthcare (VMD), reported an insider sale. The Form 4 shows a sale of 50,090 common shares on 08/12/2025 at a price of $7.33 per share. After the transaction Moore directly owns 126,343 shares and indirectly beneficially owns 1,722,614 shares through Moore Faster LLC. The filing discloses the sale but provides no context about volume relative to total outstanding shares.
Michael Moore, President of Viemed Healthcare (VMD), filed an amended Form 4 to correct his reported holdings after a sale. The amendment records a disposal of 8,948 common shares tied to the market closing price on 01/29/2025 with a per-share value shown as $8.28. The corrected post-transaction beneficial ownership is 176,433 shares, amended from an earlier reported 177,433 shares. The filing states the original error affected a prior Form 4 filed July 1 and that subsequent filings will reflect the corrected balance.
Viemed Healthcare, Inc. filed a Form S-8 to register an additional 412,351 common shares for issuance under the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended. The amendment adding these shares was approved by shareholders at the companys 2025 annual meeting on June 5, 2025. Upon effectiveness, the total shares available for issuance under the 2024 Plan will be 7,904,757. The filing incorporates by reference a prior S-8 filed on August 12, 2024 (File No. 333-281502). The registrant is identified as an accelerated filer and lists British Columbia as its jurisdiction of incorporation and Lafayette, Louisiana as its principal executive office.
Viemed Healthcare, Inc. (VMD) filed an 8-K to announce the closing of its acquisition of Lehan’s Medical Equipment, a privately held home medical equipment provider based in DeKalb, Illinois. The transaction consists of a $26 million base purchase price, subject to customary adjustments, plus an estimated $2.2 million contingent consideration.
The company stated that it will update its full-year 2025 guidance to reflect Lehan’s expected contribution when it reports Q2 2025 earnings (period ended June 30, 2025). No immediate changes to guidance or pro-forma financials were included in this filing; the related press release is furnished as Exhibit 99.1 and deemed “furnished,” not “filed,” under the Exchange Act.
For investors, the filing signals completion of a strategic bolt-on acquisition that expands VMD’s geographic reach into Illinois and broadens its home medical equipment offerings. The cash outlay and contingent payments may affect near-term liquidity, while future revenue impact will be clarified with the forthcoming guidance update.
FAQ
What is the current stock price of Viemed Healthcare (VMD)?
What is the market cap of Viemed Healthcare (VMD)?
